Nabla
Nabla sells an ambient AI assistant that listens to patient visits and writes clinical notes for doctors and other medical staff.
Raised $120M across disclosed rounds.[1][6][13]
Series C closed June 2025, led by HV Capital.[1][2][13]
post-money valuation is not publicly disclosed.
Named investors include HV Capital, Highland Europe, DST Global, Cathay Innovation, Build Collective, ZEBOX Ventures.[1][4][13]
Alexandre Lebrun, Co-founder & CEO[2][4][13][17][18]
Delphine Groll, Co-founder & COO[2][4][13][17][18]
Martin Raison, Co-founder & CTO[2][4][13][17][18]
Dr. Ed Lee, Chief Medical Officer[5]
Abridge · abridge.com · Same buyer (health systems and clinicians), same workflow (ambient clinical documentation), same budget (clinical IT spend).
Suki AI · suki.ai · Same buyer and workflow: ambient AI scribe for clinicians with EHR integration.
Nuance DAX (Microsoft) · nuance.com · Same buyer and workflow; Nuance is the incumbent enterprise solution acquired by Microsoft.
Filled in the side panel for invited readers. This card carries sourced facts only.
Jun 2026 · siliconangle.com
reported
Jun 2026 · cathayinnovation.com
unknown
Jun 2026 · techcrunch.com
reported
Jun 2026 · healthcareittoday.com
reported
Jun 2026 · nabla.com
company
Jun 2026 · prnewswire.com
company
Nabla
Nabla sells an ambient AI assistant that listens to patient visits and writes clinical notes for doctors and other medical staff.